Literature DB >> 8027503

Assessment of inflammation in noninfectious chronic maxillary sinusitis.

P Demoly1, L Crampette, M Mondain, A M Campbell, N Lequeux, I Enander, L B Schwartz, B Guerrier, F B Michel, J Bousquet.   

Abstract

BACKGROUND AND AIM: Pathologic examination of the sinus mucosa and titration of inflammatory mediators in the sinus fluid were carried out to characterize inflammation in chronic sinusitis and determine whether patients with chronic allergic rhinitis (CAR) and sinusitis differ from patients with chronic nonallergic rhinitis (CNAR) and sinusitis.
METHODS: Nine control subjects (patients requiring ear, nose, and throat surgery not related to sinusitis), 12 patients with CAR and sinusitis, and 13 patients with CNAR and sinusitis were investigated. Eosinophil cationic protein, tryptase, myeloperoxidase, histamine, and prostaglandin D2 were measured in the sinus lavage fluids, and cells were enumerated. The cellular infiltrate was studied by immunohistochemistry with monoclonal antibodies against eosinophil cationic protein (eosinophils), tryptase (mast cells), neutrophil elastase (neutrophils), CD3 (lymphocytes), CD68 (macrophages), and proliferating cell nuclear antigens.
RESULTS: Neutrophils were not increased in sinusitis. In comparison with control subjects, patients with CAR and CNAR with sinusitis showed significant increases in eosinophils and macrophages in biopsy specimens and in eosinophil cationic protein in sinus lavage fluids. In comparison with patients with CNAR, patients with CAR had an increased number of intraepithelial mast cells and lymphocytes.
CONCLUSIONS: These findings suggest that patients with CNAR and sinusitis can be distinguished from patients with CAR and sinusitis, which resembles nonallergic rhinitis with eosinophilia syndrome.

Entities:  

Mesh:

Year:  1994        PMID: 8027503     DOI: 10.1016/0091-6749(94)90076-0

Source DB:  PubMed          Journal:  J Allergy Clin Immunol        ISSN: 0091-6749            Impact factor:   10.793


  10 in total

1.  Sinus computed tomography scan and markers of inflammation in vocal cord dysfunction and asthma.

Authors:  Edward J Peters; Tina K Hatley; Scott E Crater; C Douglas Phillips; Thomas A E Platts-Mills; Larry Borish
Journal:  Ann Allergy Asthma Immunol       Date:  2003-03       Impact factor: 6.347

2.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipo; Israel Rubinstein
Journal:  Curr Infect Dis Rep       Date:  2007-05       Impact factor: 3.725

Review 3.  Anti-inflammatory treatment of chronic rhinosinusitis: a shifting paradigm.

Authors:  Umur Hatipoğlu; Israel Rubinstein
Journal:  Curr Allergy Asthma Rep       Date:  2008-04       Impact factor: 4.806

Review 4.  [Asthma, allergic rhinitis, sinusitis. Concept of the "unified respiratory tracts"].

Authors:  J C Virchow
Journal:  HNO       Date:  2005-05       Impact factor: 1.284

Review 5.  Fungi in chronic hyperplastic eosinophilic sinusitis: reasonable doubt.

Authors:  Larry Borish; Lanny Rosenwasser; John W Steinke
Journal:  Clin Rev Allergy Immunol       Date:  2006-06       Impact factor: 8.667

Review 6.  Nasal cytokines as mediators of illness during the common cold.

Authors:  William J Doyle; David P Skoner; Deborah Gentile
Journal:  Curr Allergy Asthma Rep       Date:  2005-05       Impact factor: 4.806

Review 7.  The relationship between rhinosinusitis and asthma sinusitis.

Authors:  John W Steinke
Journal:  Curr Allergy Asthma Rep       Date:  2006-11       Impact factor: 4.919

Review 8.  Treatment of chronic rhinosinusitis with low-dose, long-term macrolide antibiotics: an evolving paradigm.

Authors:  Umur Hatipoglu; Israel Rubinstein
Journal:  Curr Allergy Asthma Rep       Date:  2005-11       Impact factor: 4.919

Review 9.  Management of the patient with eosinophilic asthma: a new era begins.

Authors:  Jantina C de Groot; Anneke Ten Brinke; Elisabeth H D Bel
Journal:  ERJ Open Res       Date:  2015-09-23

Review 10.  Host-microbial interactions in patients with chronic rhinosinusitis.

Authors:  Daniel L Hamilos
Journal:  J Allergy Clin Immunol       Date:  2013-11-28       Impact factor: 10.793

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.